FDA review of oral MS drug FTY720 extended

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

FDA review of oral MS drug FTY720 extended

Postby MSUK » Tue May 25, 2010 1:12 am

Image

Novartis International AG / Novartis announces extension of US regulatory priority review period for FTY720, an investigational once-daily oral multiple sclerosis therapy.

* US Food and Drug Administration (FDA) extends priority review period by three months to September 2010, in line with previously announced expectations............. [Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1309 ]
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2180
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Postby Lo » Tue May 25, 2010 5:15 pm

Thanks for the update.
Lo
Family Member
 
Posts: 33
Joined: Tue Apr 13, 2010 3:00 pm
Location: Florida


Return to General Discussion

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service